SlideShare une entreprise Scribd logo
1  sur  31
PESTLE ANAYLSIS ON PHARMACEUTICAL INDUSTRY IN ITALY
 Italy is a country in Europe
 Rome is capital city of Italy
 Area is 301,225 square kms
 Population is approx. 61 million
Italian is the official language
Currency of Italy is Euro since 2002
June 2 – Republic day, celebrating the
constitution in 1946.
Roman Catholicism is the predominant
religion of Italy
POLITICAL
• Unitary Parliamentary Republic since 2 June 1946
• President is head of state and Prime Minister is head of
government
Sergio Matarella Matteo Renzi Beatrice Lorenzine
President :-
• No Executive powers
• Ensure laws follow the constitution
• Appoints PM and can terminate Congress
Prime Minister :-
• Has Executive powers
• Coordinate intelligence policies, determines the financial
resources and strengthens national cyber security
Parliament :-
• Bicarmel legislature
• Houses are Senate of Republic and Chamber of Deputies
Senate of Republic :-
• Upper house of parliament
• 315 elected Senators and 6 lifetime
senators
• Term of office is 5 years
Pallazo Madama
Pallazo Madama
Chamber of Deputies :-
• Lower house of parliament
• Has 630 seats, of which 618 are
elected from Italian constituencies
and 12 from Italian citizens living
aborad
Pallazo Montecitorio
DID YOU KNOW???
ECONOMICAL
The pharmaceutical industry is one of the main motors of Italy’s
economic recovery. Exports have reached a record high (a yearly
growth rate of 4.5%), and investments are on the rise along with the
sector’s employment.
The Italian pharmaceutical industry is second in Europe for
production volume and the first in the world for exports: +71% of
Italy’s production is exported.
Pharmaceuticals in Italy rank top in European manufacturing
With reference to the value of pharmaceutical manufacturing, Italy
ranks 2nd in big EU countries after Germany, but ranks 1st for per
capita manufacturing value.( 1 Euro = 74.9535 Rs)
Italy registered the highest increase in the world of
medicines export between 2010 and 2014
Italy could be the European pharmaceutical hub with policies
that make the country increasingly attractive to FDI
Pharmaceutical growth on international markets
The export growth is rooted in the high competitiveness of
manufacturing in Italy, which reflects investments by enterprises and
the quality of its Human Resources
174 manufacturing plants
63,000 employees
(90% graduates)
and other 65,000 in upstream sectors
5,950 R&D employees
€ 29 billion of manufacturing value,
of which 72% for export (€20.7 billions)
€ 2.5 billion in investments,
of which €1.3 in R&D
and €1.2 in hi-tech plants and machinery
+71% export growth in the last 5 years
compared to +38% in overall manufacturing
DID YOU KNOW???
SOCIO-CULTURAL
• According to Giampaolo Zambeletti, chairman
of Ellem Industria Farmaceutica,
• Socio-cultural attitudes towards health care
provision has revealed a continued weakening
in the physician/ patient relationship over the
last 10 years
• The culture of prevention had been almost
completely absent among Italian health care
consumers
• Now people are better educated (Literacy
rate: 97%) in medical and pharmaceutical
matters, more interested in such matters and
more concerned about their own health
• For the pharmaceutical industry, these trends
point up the need to develop a new service-
oriented culture
Companies have develop new strategies that include:
– a full information service to the physician, including
education and updating
– drug information to include consideration of factors such
as the product's affect which varies over time, and
cost/benefit information;
– the concept of the "European" customer to be developed
and standardized, both directly and indirectly; and
– developing interactive communications, making them a
two-way exchange rather than simply coming from the
top.
DID YOU KNOW???
TECHNOLOGICAL
The technological factors relate to the application
of new inventions and ideas such as R&D activity,
automation, technology incentives and the rate of
technological change.
• Linking mail order internet technology with traditional pharmacies
into multi channel shopping experience
• Massive uptake of social media and smart phones
• Rapid growth in tech savy multi channel pharmacy shoppers
• Emergence of want it now shopper expectations using online
marketing services
• Good presence of online marketing service
• High percentage of R&D expenditure
DID YOU KNOW???
LEGAL
AIFA (Agenzia italiana del farmaco) 2004
The Italian medicines agency. It is the national authority responsible for drug
authority in Italy
It cooperates with the Regional Authorities, the National Institute of Health,
Research Institutes, Patients’ Associations, Health Professionals, Scientific
Associations the Pharmaceutical Industry and the Distributors.
The mission:
- Promote good health through medicines
More specifically, the Agency:
• Guarantees access to medicines and their safe and appropriate use.
• Ensures unity of the national pharmaceutical system in agreement with the
regional authorities;
• Ensures innovation, efficiency and simplification of the marketing authorization
procedures, in order to grant rapid access to innovative drugs and to drugs used
for rare diseases;
• Provides drug expenditure governance in the framework of economic and
financial viability and competitiveness of the pharmaceutical industry;
• Encourages investments in research & development in Italy;
• AIFA also verifies the implementation of national and European laws
regarding the distribution, importation, exportation and smooth
operation of early warning and emergency management.
• The phenomenon and the Database on thefts
In 2013 theft cases. In order to share and analyze data and information
on the phenomenon AIFA along with Ministry of Health, set up a
database on thefts, an archive constantly updated with data shared by
the over thirty companies participating in the project.
The Database, hosted and managed by AIFA, is available online to
authorized users (member companies and police forces).
• Stolen medicines
This section makes available information of medicinal products stolen in
Italy. The aim is to provide useful and timely updates to all operators in
order to intercept any "suspect offers," potentially related to illegal
activities.
• Training
Several training initiatives on the issue of counterfeiting and the
importation of illegal drugs have been organized and promoted by AIFA.
• E-Pharmacies
• Italian law prohibits e-pharmacies but can not prevent Italian customers
from buying from foreign e-pharmacies.
OTHER LAWS
• Italy's pharmaceutical patents were prohibited until 1978.
• After 1978 supreme court ruled in favour of 18 foreign pharmacy
companies requesting the enforcement of patents on medical products in
Italy.
• Despite of lack of any patent protection it has developed a strong
pharmacy industry and end of 1970 it was 5th world producer of pharma
and 7th exporter.
• 50% -80 % pediatrics drugs are not been tested on children or not been
licensed, in this case physician have to take responsibility
• Marketing authorization no EU nine digits
• A pharmacy company needs to be registered and incorporated at relevant
tax authorities. Pharmaceutical products are subject to VAT (10% -21%)
• Two procedures available national procedure and community procedure
DID YOU KNOW???
ENVIRONMENTAL ANALYSIS
Environmental contamination by pharmaceuticals is
an emerging issue.
Pharmaceuticals waste are widespread
contaminants, entering the environment from a
myriad of scattered points.
The sewage system is an important point in the
control of contamination, but sewage treatment
plants are not able efficiently to abate a substantial
part of water-borne pharmaceuticals.
Grazie!!!

Contenu connexe

Tendances

Pestle analysis
Pestle analysisPestle analysis
Pestle analysisCOEPD HR
 
Mankind corporate presentation
Mankind corporate presentationMankind corporate presentation
Mankind corporate presentationAnkit Khandelewal
 
SWOT & PESTEL ANALYSIS OF HUL.pptx
SWOT & PESTEL ANALYSIS OF HUL.pptxSWOT & PESTEL ANALYSIS OF HUL.pptx
SWOT & PESTEL ANALYSIS OF HUL.pptxmanhar4
 
Porter’s generic competitive strategies
Porter’s generic competitive strategiesPorter’s generic competitive strategies
Porter’s generic competitive strategiesChetna Setia
 
Industry and competitor analysis
Industry and competitor analysisIndustry and competitor analysis
Industry and competitor analysisyusramahar
 
Segmenting, Targeting and Positioning of the toothpaste industry
Segmenting, Targeting and Positioning of the toothpaste industrySegmenting, Targeting and Positioning of the toothpaste industry
Segmenting, Targeting and Positioning of the toothpaste industrySohinee Dabeedyal
 
Competitive Analysis in Pharmaceutical Industry
Competitive Analysis in Pharmaceutical IndustryCompetitive Analysis in Pharmaceutical Industry
Competitive Analysis in Pharmaceutical IndustryYee Jie NG
 
Swot incepta pharmaceuticals ltd.
Swot incepta pharmaceuticals ltd.Swot incepta pharmaceuticals ltd.
Swot incepta pharmaceuticals ltd.bappykazi
 
Pharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysisPharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysisRahul Pagaria
 
STRATEGIC MANAGEMENT
STRATEGIC MANAGEMENTSTRATEGIC MANAGEMENT
STRATEGIC MANAGEMENTTreesa Jos
 
Strategic Management- TOWS Matrix
Strategic Management- TOWS MatrixStrategic Management- TOWS Matrix
Strategic Management- TOWS MatrixSachin Udhani
 
A Presentation on "Johnson & Johnson"
A Presentation on  "Johnson & Johnson"A Presentation on  "Johnson & Johnson"
A Presentation on "Johnson & Johnson"Rahul Dey
 

Tendances (20)

Pestle analysis
Pestle analysisPestle analysis
Pestle analysis
 
Sap
SapSap
Sap
 
Mankind corporate presentation
Mankind corporate presentationMankind corporate presentation
Mankind corporate presentation
 
Sun pharma ppt
Sun pharma pptSun pharma ppt
Sun pharma ppt
 
SWOT & PESTEL ANALYSIS OF HUL.pptx
SWOT & PESTEL ANALYSIS OF HUL.pptxSWOT & PESTEL ANALYSIS OF HUL.pptx
SWOT & PESTEL ANALYSIS OF HUL.pptx
 
Ansoff Matrix
Ansoff MatrixAnsoff Matrix
Ansoff Matrix
 
Porter’s generic competitive strategies
Porter’s generic competitive strategiesPorter’s generic competitive strategies
Porter’s generic competitive strategies
 
Industry and competitor analysis
Industry and competitor analysisIndustry and competitor analysis
Industry and competitor analysis
 
Segmenting, Targeting and Positioning of the toothpaste industry
Segmenting, Targeting and Positioning of the toothpaste industrySegmenting, Targeting and Positioning of the toothpaste industry
Segmenting, Targeting and Positioning of the toothpaste industry
 
Ansoff matrix
Ansoff matrixAnsoff matrix
Ansoff matrix
 
Competitive Analysis in Pharmaceutical Industry
Competitive Analysis in Pharmaceutical IndustryCompetitive Analysis in Pharmaceutical Industry
Competitive Analysis in Pharmaceutical Industry
 
Swot incepta pharmaceuticals ltd.
Swot incepta pharmaceuticals ltd.Swot incepta pharmaceuticals ltd.
Swot incepta pharmaceuticals ltd.
 
Expansion strategies
Expansion strategiesExpansion strategies
Expansion strategies
 
Pharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysisPharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysis
 
Market targeting
Market targetingMarket targeting
Market targeting
 
Forecasting and demand measurement
Forecasting and demand measurementForecasting and demand measurement
Forecasting and demand measurement
 
STRATEGIC MANAGEMENT
STRATEGIC MANAGEMENTSTRATEGIC MANAGEMENT
STRATEGIC MANAGEMENT
 
Ansoff matrix
Ansoff matrixAnsoff matrix
Ansoff matrix
 
Strategic Management- TOWS Matrix
Strategic Management- TOWS MatrixStrategic Management- TOWS Matrix
Strategic Management- TOWS Matrix
 
A Presentation on "Johnson & Johnson"
A Presentation on  "Johnson & Johnson"A Presentation on  "Johnson & Johnson"
A Presentation on "Johnson & Johnson"
 

Similaire à PESTLE ANAYLSIS ON PHARMACEUTICAL INDUSTRY IN ITALY

Europe Telemedicine Market Analysis Sample Report
Europe Telemedicine Market Analysis Sample ReportEurope Telemedicine Market Analysis Sample Report
Europe Telemedicine Market Analysis Sample ReportInsights10
 
Why France Connected Health Challenges Paris 15 March 2012
Why France Connected Health Challenges   Paris 15 March 2012Why France Connected Health Challenges   Paris 15 March 2012
Why France Connected Health Challenges Paris 15 March 2012DGAshley
 
Sandra Liede: The Finnish Genome Strategy and the Genome Law
Sandra Liede: The Finnish Genome Strategy and the Genome LawSandra Liede: The Finnish Genome Strategy and the Genome Law
Sandra Liede: The Finnish Genome Strategy and the Genome LawTHL
 
Funding of health promotion foundations - Gonda Perez & Roshan Galvaan
Funding of health promotion foundations - Gonda Perez & Roshan GalvaanFunding of health promotion foundations - Gonda Perez & Roshan Galvaan
Funding of health promotion foundations - Gonda Perez & Roshan GalvaanNCAS1
 
Public health and intellectual property
Public health and intellectual propertyPublic health and intellectual property
Public health and intellectual propertyDawal Salve
 
Pharmaceutical industry
Pharmaceutical industryPharmaceutical industry
Pharmaceutical industryApurv Singh
 
Italy Dental Care Market Analysis Sample Report
Italy Dental Care Market Analysis Sample ReportItaly Dental Care Market Analysis Sample Report
Italy Dental Care Market Analysis Sample ReportInsights10
 
Tobacco products implications and policies
Tobacco products implications and policiesTobacco products implications and policies
Tobacco products implications and policiesVenkatesh Makkena
 
DPA Conference - Innternational Reform Drug Policy Conference, LA, USA 2011
DPA Conference - Innternational Reform Drug Policy Conference, LA, USA 2011DPA Conference - Innternational Reform Drug Policy Conference, LA, USA 2011
DPA Conference - Innternational Reform Drug Policy Conference, LA, USA 2011Paula Vale de Andrade
 
R. VILLANO - COLOPHON LIBRO RIFORME SERVIZIO F.CO 1860-2008 EN-2017
R. VILLANO - COLOPHON LIBRO  RIFORME  SERVIZIO  F.CO  1860-2008  EN-2017R. VILLANO - COLOPHON LIBRO  RIFORME  SERVIZIO  F.CO  1860-2008  EN-2017
R. VILLANO - COLOPHON LIBRO RIFORME SERVIZIO F.CO 1860-2008 EN-2017Raimondo Villano
 
Dr Dev Kambhampati | Doing Business in Italy - 2014 Country Commercial Guide ...
Dr Dev Kambhampati | Doing Business in Italy - 2014 Country Commercial Guide ...Dr Dev Kambhampati | Doing Business in Italy - 2014 Country Commercial Guide ...
Dr Dev Kambhampati | Doing Business in Italy - 2014 Country Commercial Guide ...Dr Dev Kambhampati
 

Similaire à PESTLE ANAYLSIS ON PHARMACEUTICAL INDUSTRY IN ITALY (20)

Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
 
Pharmacy
PharmacyPharmacy
Pharmacy
 
He. ppt
He. pptHe. ppt
He. ppt
 
Pharmaceuticals
PharmaceuticalsPharmaceuticals
Pharmaceuticals
 
Connected Health - Around the World in 60 Minutes
Connected Health - Around the World in 60 MinutesConnected Health - Around the World in 60 Minutes
Connected Health - Around the World in 60 Minutes
 
Europe Telemedicine Market Analysis Sample Report
Europe Telemedicine Market Analysis Sample ReportEurope Telemedicine Market Analysis Sample Report
Europe Telemedicine Market Analysis Sample Report
 
Why France Connected Health Challenges Paris 15 March 2012
Why France Connected Health Challenges   Paris 15 March 2012Why France Connected Health Challenges   Paris 15 March 2012
Why France Connected Health Challenges Paris 15 March 2012
 
Sandra Liede: The Finnish Genome Strategy and the Genome Law
Sandra Liede: The Finnish Genome Strategy and the Genome LawSandra Liede: The Finnish Genome Strategy and the Genome Law
Sandra Liede: The Finnish Genome Strategy and the Genome Law
 
Status AT ICT usage in Europe
Status AT ICT usage in EuropeStatus AT ICT usage in Europe
Status AT ICT usage in Europe
 
Funding of health promotion foundations - Gonda Perez & Roshan Galvaan
Funding of health promotion foundations - Gonda Perez & Roshan GalvaanFunding of health promotion foundations - Gonda Perez & Roshan Galvaan
Funding of health promotion foundations - Gonda Perez & Roshan Galvaan
 
Public health and intellectual property
Public health and intellectual propertyPublic health and intellectual property
Public health and intellectual property
 
eHealth in Europe: Rules and Regulations
eHealth in Europe: Rules and RegulationseHealth in Europe: Rules and Regulations
eHealth in Europe: Rules and Regulations
 
Pharmaceutical industry
Pharmaceutical industryPharmaceutical industry
Pharmaceutical industry
 
Italy Dental Care Market Analysis Sample Report
Italy Dental Care Market Analysis Sample ReportItaly Dental Care Market Analysis Sample Report
Italy Dental Care Market Analysis Sample Report
 
Unit 3 Regulatory affairs.pdf
Unit 3 Regulatory affairs.pdfUnit 3 Regulatory affairs.pdf
Unit 3 Regulatory affairs.pdf
 
Tobacco products implications and policies
Tobacco products implications and policiesTobacco products implications and policies
Tobacco products implications and policies
 
LITHUANIA_EN_v5
LITHUANIA_EN_v5LITHUANIA_EN_v5
LITHUANIA_EN_v5
 
DPA Conference - Innternational Reform Drug Policy Conference, LA, USA 2011
DPA Conference - Innternational Reform Drug Policy Conference, LA, USA 2011DPA Conference - Innternational Reform Drug Policy Conference, LA, USA 2011
DPA Conference - Innternational Reform Drug Policy Conference, LA, USA 2011
 
R. VILLANO - COLOPHON LIBRO RIFORME SERVIZIO F.CO 1860-2008 EN-2017
R. VILLANO - COLOPHON LIBRO  RIFORME  SERVIZIO  F.CO  1860-2008  EN-2017R. VILLANO - COLOPHON LIBRO  RIFORME  SERVIZIO  F.CO  1860-2008  EN-2017
R. VILLANO - COLOPHON LIBRO RIFORME SERVIZIO F.CO 1860-2008 EN-2017
 
Dr Dev Kambhampati | Doing Business in Italy - 2014 Country Commercial Guide ...
Dr Dev Kambhampati | Doing Business in Italy - 2014 Country Commercial Guide ...Dr Dev Kambhampati | Doing Business in Italy - 2014 Country Commercial Guide ...
Dr Dev Kambhampati | Doing Business in Italy - 2014 Country Commercial Guide ...
 

Dernier

Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024Janet Corral
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...PsychoTech Services
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 

Dernier (20)

Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 

PESTLE ANAYLSIS ON PHARMACEUTICAL INDUSTRY IN ITALY

  • 1. PESTLE ANAYLSIS ON PHARMACEUTICAL INDUSTRY IN ITALY
  • 2.  Italy is a country in Europe  Rome is capital city of Italy  Area is 301,225 square kms  Population is approx. 61 million Italian is the official language Currency of Italy is Euro since 2002 June 2 – Republic day, celebrating the constitution in 1946. Roman Catholicism is the predominant religion of Italy
  • 4. • Unitary Parliamentary Republic since 2 June 1946 • President is head of state and Prime Minister is head of government Sergio Matarella Matteo Renzi Beatrice Lorenzine
  • 5. President :- • No Executive powers • Ensure laws follow the constitution • Appoints PM and can terminate Congress Prime Minister :- • Has Executive powers • Coordinate intelligence policies, determines the financial resources and strengthens national cyber security Parliament :- • Bicarmel legislature • Houses are Senate of Republic and Chamber of Deputies
  • 6. Senate of Republic :- • Upper house of parliament • 315 elected Senators and 6 lifetime senators • Term of office is 5 years Pallazo Madama Pallazo Madama Chamber of Deputies :- • Lower house of parliament • Has 630 seats, of which 618 are elected from Italian constituencies and 12 from Italian citizens living aborad Pallazo Montecitorio
  • 9. The pharmaceutical industry is one of the main motors of Italy’s economic recovery. Exports have reached a record high (a yearly growth rate of 4.5%), and investments are on the rise along with the sector’s employment. The Italian pharmaceutical industry is second in Europe for production volume and the first in the world for exports: +71% of Italy’s production is exported.
  • 10. Pharmaceuticals in Italy rank top in European manufacturing With reference to the value of pharmaceutical manufacturing, Italy ranks 2nd in big EU countries after Germany, but ranks 1st for per capita manufacturing value.( 1 Euro = 74.9535 Rs)
  • 11. Italy registered the highest increase in the world of medicines export between 2010 and 2014 Italy could be the European pharmaceutical hub with policies that make the country increasingly attractive to FDI
  • 12. Pharmaceutical growth on international markets The export growth is rooted in the high competitiveness of manufacturing in Italy, which reflects investments by enterprises and the quality of its Human Resources
  • 13. 174 manufacturing plants 63,000 employees (90% graduates) and other 65,000 in upstream sectors 5,950 R&D employees € 29 billion of manufacturing value, of which 72% for export (€20.7 billions) € 2.5 billion in investments, of which €1.3 in R&D and €1.2 in hi-tech plants and machinery +71% export growth in the last 5 years compared to +38% in overall manufacturing
  • 16. • According to Giampaolo Zambeletti, chairman of Ellem Industria Farmaceutica, • Socio-cultural attitudes towards health care provision has revealed a continued weakening in the physician/ patient relationship over the last 10 years • The culture of prevention had been almost completely absent among Italian health care consumers
  • 17. • Now people are better educated (Literacy rate: 97%) in medical and pharmaceutical matters, more interested in such matters and more concerned about their own health • For the pharmaceutical industry, these trends point up the need to develop a new service- oriented culture
  • 18. Companies have develop new strategies that include: – a full information service to the physician, including education and updating – drug information to include consideration of factors such as the product's affect which varies over time, and cost/benefit information; – the concept of the "European" customer to be developed and standardized, both directly and indirectly; and – developing interactive communications, making them a two-way exchange rather than simply coming from the top.
  • 21. The technological factors relate to the application of new inventions and ideas such as R&D activity, automation, technology incentives and the rate of technological change.
  • 22. • Linking mail order internet technology with traditional pharmacies into multi channel shopping experience • Massive uptake of social media and smart phones • Rapid growth in tech savy multi channel pharmacy shoppers • Emergence of want it now shopper expectations using online marketing services • Good presence of online marketing service • High percentage of R&D expenditure
  • 23.
  • 25. LEGAL
  • 26. AIFA (Agenzia italiana del farmaco) 2004 The Italian medicines agency. It is the national authority responsible for drug authority in Italy It cooperates with the Regional Authorities, the National Institute of Health, Research Institutes, Patients’ Associations, Health Professionals, Scientific Associations the Pharmaceutical Industry and the Distributors. The mission: - Promote good health through medicines More specifically, the Agency: • Guarantees access to medicines and their safe and appropriate use. • Ensures unity of the national pharmaceutical system in agreement with the regional authorities; • Ensures innovation, efficiency and simplification of the marketing authorization procedures, in order to grant rapid access to innovative drugs and to drugs used for rare diseases; • Provides drug expenditure governance in the framework of economic and financial viability and competitiveness of the pharmaceutical industry; • Encourages investments in research & development in Italy;
  • 27. • AIFA also verifies the implementation of national and European laws regarding the distribution, importation, exportation and smooth operation of early warning and emergency management. • The phenomenon and the Database on thefts In 2013 theft cases. In order to share and analyze data and information on the phenomenon AIFA along with Ministry of Health, set up a database on thefts, an archive constantly updated with data shared by the over thirty companies participating in the project. The Database, hosted and managed by AIFA, is available online to authorized users (member companies and police forces). • Stolen medicines This section makes available information of medicinal products stolen in Italy. The aim is to provide useful and timely updates to all operators in order to intercept any "suspect offers," potentially related to illegal activities. • Training Several training initiatives on the issue of counterfeiting and the importation of illegal drugs have been organized and promoted by AIFA. • E-Pharmacies • Italian law prohibits e-pharmacies but can not prevent Italian customers from buying from foreign e-pharmacies.
  • 28. OTHER LAWS • Italy's pharmaceutical patents were prohibited until 1978. • After 1978 supreme court ruled in favour of 18 foreign pharmacy companies requesting the enforcement of patents on medical products in Italy. • Despite of lack of any patent protection it has developed a strong pharmacy industry and end of 1970 it was 5th world producer of pharma and 7th exporter. • 50% -80 % pediatrics drugs are not been tested on children or not been licensed, in this case physician have to take responsibility • Marketing authorization no EU nine digits • A pharmacy company needs to be registered and incorporated at relevant tax authorities. Pharmaceutical products are subject to VAT (10% -21%) • Two procedures available national procedure and community procedure
  • 30. ENVIRONMENTAL ANALYSIS Environmental contamination by pharmaceuticals is an emerging issue. Pharmaceuticals waste are widespread contaminants, entering the environment from a myriad of scattered points. The sewage system is an important point in the control of contamination, but sewage treatment plants are not able efficiently to abate a substantial part of water-borne pharmaceuticals.